Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Combination Treatment With Methotrexate and Cyclosporine in Early Rheumatoid Arthritis

Next Previous
Trial Profile

Combination Treatment With Methotrexate and Cyclosporine in Early Rheumatoid Arthritis

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Jan 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ciclosporin (Primary) ; Betamethasone; Methotrexate
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms CIMESTRA

Most Recent Events

  • 09 Nov 2021 Results assessing plasma levels of CXCL13, and its ability to predict radiographic joint destruction, presented at the ACR Convergence 2021.
  • 06 Jun 2020 Results assessing vitamin D trajectories from time of diagnosis through 10 years follow-up in early diagnosed RA patients presented at the 21st Annual Congress of the European League Against Rheumatism
  • 01 Jul 2018 Results of post-hoc analysis from CIMESTRA and OPERA trials published in the Scandinavian Journal of Rheumatology.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top